Company* (Country; Symbol) |
Company* (Country; Symbol) |
Product |
Terms/Details (Date) |
| | |||
Affymetrix |
Ingenuity Systems* |
Ingenuity Pathways Analysis product |
Ingenuity will deliver the product to Affymetrix customers; Affymetrix made an undisclosed equity investment in Ingenuity (8/11) |
|
|
|
|
Akers |
The Medicines Co. (MDCO) |
Akers' Rapid HeparinPlatelet Factor-4 antibody test |
The Medicines Co. will increase awareness and market the test once it receives regulatory approval (7/2) |
|
|
||
Amphioxus |
Pierce Inc.* |
Products used in the sequential process of target identification and validation specific to kinases, phosphatases and ADME-TOX |
Companies formed a co-marketing agreement for the Pierce IQ Kinase Assay Platform and the ACTIV-Tox Drug Discovery Platform of Amphioxus Cell (8/13) |
|
|
|
|
Cobra Biomanufacturing (UK;LSE:CBF) |
Advaxis Inc.* |
Listeria monocytogenes-based cancer vaccine's active ingredient |
Cobra won a contract to supply the active ingredient for a Listeria monocytogenes-based cancer vaccine to Advaxis (8/6**) |
|
|||
Corixa |
Meridian Bioscience Inc. (VIVO) |
A recombinant Trypanosoma cruzi (Chagas' disease) antigen |
Meridian is producing the antigen at its laboratories located at Viral Antigens Inc.; the antigen known as TcF will be marketed to diagnostic test manufacturers for use in production of test kits for blood bank screening and other diagnostic applications (7/21) |
|
|
||
Incyte |
Linden |
Amplification kits for research use |
Linden will manufacture and sell the kits for research use directed to linear mRNA amplification technology exclusively licensed to Incyte (7/7) |
|
|
|
|
Lonza |
Vaccinex Inc.* |
Recombinant proteins and antibody products |
Lonza will provide Vaccinex, its clients and partners with access to its Glutamine Synthetase Gene Expression system; Lonza also will provide access to its cGMP manu- facturing facilities for the clinical pro- duction of recombinant proteins and anti-body products (7/11) |
|
|
|
|
MDS Sciex |
LEAP Technologies |
NanoLC proteomics system |
LEAP will distribute the new NanoLC proteomics system in the U.S. (8/5) |
|
|
|
|
Progenitor Cell Therapy LLC* |
Proneuron Biotechnologies Inc.* |
Clinical trial-grade human cells |
Progenitor Cell will manufacture auto- logous cells for evaluating therapeutic efficacy in patients with recent spinal cord damage, using Proneuron's ProCord technology (6/25) |
|
|
||
Qiagen NV (the Netherlands; QGENF) |
Intradigm Corp.* |
Small interfering RNA |
Qiagen will manufacture and provide Intradigm with siRNA agents for research programs in several disease areas, including oncology, arthritis and severe acute respiratory syndrome coronavirus infection (7/8) |
| | |||
Notes: | |||
# The information in the chart does not cover agricultural agreements. | |||
* Private companies are indicated with an asterisk. ** Denotes the date the item ran in BioWorld International. | |||
Unless otherwise noted, stock symbols listed are on the Nasdaq market. | |||
LSE = London Stock Exchange; NYSE = New York Stock Exchange; TSE = Toronto Stock Exchange. | |||
